Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
GPI S.p.A. (GPI.MI)
Trento, TN, IT
GPI S.p.A. delivers specialized IT and high-tech services to the healthcare and social-healthcare markets. The company develops a wide range of software solutions covering critical areas such as health administration, clinical systems, social care, blood and tissue banking, human resource management, continuum care, public administration, safety and prevention, chronic illness management, patient care, business intelligence, data analytics, health cooperation, and people relationship management. Beyond software, GPI delivers key healthcare administration services, including advanced centralized booking and contract systems designed to significantly reduce patient waiting times, alongside innovative healthcare technologies and broader healthcare support. Their product portfolio features the Phasys System, an integrated hardware and software platform for optimizing medication management in healthcare facilities, and the RIEDL Phasys System, which automates medicine distribution within pharmacies. Furthermore, GPI offers general ICT services, payment solutions for both public administration and retail, and a comprehensive suite of desktop services. These desktop services encompass the design, implementation, and ongoing maintenance of technological infrastructures; IT consultancy and support; provision of solutions for public administrations; and help desk and facility management for a diverse clientele including local and central public bodies, healthcare providers, multi-utilities, and private enterprises. They also specialize in trouble ticketing systems and the design of integrated technological solutions. Established in 1988 and headquartered in Trento, Italy, GPI S.p.A. operates as a subsidiary of FM S.r.l.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.75% | +1.71% | -3.85% | -10.83% | -7.53% | -1.78% | +48.56% | +37.72% | +22.37% | +58.77% | +60.41% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+4.0% Q4'25: +18.6% (vs Q4'23)
-
EPS growth Conglomerates: +16.9%-84.4% Q4'25: +87.0% (vs Q4'23)
-
FCF margin FCF growth · Conglomerates: +35.9%-1.9% Q4'25: -2.7% (vs Q4'23)
-
EBIT margin Conglomerates: +9.0%+6.2% Q4'25: +7.8% (vs Q4'23)
-
ROIC Conglomerates: +4.7%+3.7% Q4'25: +10.4% (vs Q4'23)
-
Share dilution Conglomerates: +0.0%+0.0% Q4'25: +0.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×5.45× Q4'25: 2.33× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 3 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
135.12M
est: 131.10M (+3.1%)
|
178.81M
est: 179.74M (-0.5%)
|
201.86M
est: 199.41M (+1.2%)
|
236.96M
est: 236.60M (+0.2%)
|
268.36M
est: 270.00M (-0.6%)
|
323.89M
est: 326.00M (-0.6%)
|
346.95M
est: 355.67M (-2.5%)
|
433.42M
est: 484.01M (-10.5%)
|
509.70M
est: 507.43M (+0.4%)
|
530.25M
est: 555.27M (-4.5%)
|
585.13M
576.69M – 602.00M
+5.4% YoY
|
612.91M
589.40M – 637.80M
+4.7% YoY
|
625.79M
625.79M – 625.79M
+2.1% YoY
|
| EBITDA |
18.01M
est: 20.53M (-12.3%)
|
22.92M
est: 28.15M (-18.6%)
|
24.47M
est: 31.23M (-21.7%)
|
32.34M
est: 37.06M (-12.7%)
|
38.65M
est: 42.29M (-8.6%)
|
47.35M
est: 51.06M (-7.3%)
|
48.60M
est: 55.71M (-12.8%)
|
67.96M
est: 104.49M (-35.0%)
|
99.93M
est: 109.55M (-8.8%)
|
89.03M
est: 119.88M (-25.7%)
|
126.32M
124.50M – 129.96M
+5.4% YoY
|
132.32M
127.24M – 137.69M
+4.7% YoY
|
135.10M
135.10M – 135.10M
+2.1% YoY
|
| EBIT |
14.66M
est: 9.36M (+56.5%)
|
15.45M
est: 12.84M (+20.4%)
|
15.01M
est: 14.24M (+5.4%)
|
16.20M
est: 16.90M (-4.1%)
|
18.03M
est: 19.28M (-6.5%)
|
22.90M
est: 23.28M (-1.7%)
|
21.44M
est: 25.40M (-15.6%)
|
28.32M
est: 32.98M (-14.1%)
|
46.87M
est: 34.57M (+35.6%)
|
32.76M
est: 37.83M (-13.4%)
|
39.87M
39.29M – 41.02M
+5.4% YoY
|
41.76M
40.16M – 43.45M
+4.7% YoY
|
42.64M
42.64M – 42.64M
+2.1% YoY
|
| Net Income |
6.23M
|
7.87M
est: 15.02M (-47.6%)
|
9.23M
est: 16.18M (-43.0%)
|
9.36M
est: 15.31M (-38.9%)
|
11.99M
est: 21.34M (-43.8%)
|
11.05M
est: 26.87M (-58.9%)
|
9.72M
est: 16.13M (-39.7%)
|
7.19M
est: 8.93M (-19.5%)
|
104.04M
est: 14.42M (+621.5%)
|
16.19M
est: 24.07M (-32.7%)
|
27.89M
27.76M – 28.03M
+15.9% YoY
|
30.71M
30.70M – 30.72M
+10.1% YoY
|
33.16M
32.90M – 33.42M
+8.0% YoY
|
| SGA |
11.60M
est: 2.42M (+378.7%)
|
19.34M
est: 3.32M (+482.2%)
|
25.93M
est: 3.68M (+603.6%)
|
20.30M
est: 4.37M (+364.3%)
|
4.25M
est: 4.99M (-14.8%)
|
17.91M
est: 6.02M (+197.3%)
|
1.37M
est: 6.57M (-79.2%)
|
1.40M
est: 14.85M (-90.6%)
|
7.18M
est: 15.57M (-53.8%)
|
40.74M
est: 17.03M (+139.2%)
|
17.95M
17.69M – 18.47M
+5.4% YoY
|
18.80M
18.08M – 19.56M
+4.7% YoY
|
19.20M
19.20M – 19.20M
+2.1% YoY
|
| EPS |
0.41
|
0.48
est: 0.52 (-7.7%)
|
0.58
est: 0.56 (+3.6%)
|
0.60
est: 0.53 (+13.2%)
|
0.76
est: 0.74 (+2.9%)
|
0.61
est: 0.93 (-34.4%)
|
0.34
est: 0.56 (-39.1%)
|
0.25
est: 0.31 (-19.4%)
|
3.60
est: 0.50 (+625.0%)
|
0.56
est: 0.83 (-32.8%)
|
0.97
0.96 – 0.97
+15.9% YoY
|
1.06
1.06 – 1.06
+10.1% YoY
|
1.15
1.14 – 1.16
+8.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 2/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.16% | 150.2K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.16% | 150.2K | 0.38% |
| 3 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.06% | 260.3K | 0.48% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.06% | 605.0K | 0.58% |
| 5 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 21.9K | 0.30% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.00% | 109.9K | 0.39% |
| 7 | Dimensional - International Small Cap Value ETF DISV | 0.00% | 65.2K | 0.42% |
| 8 | Dimensional - International Vector Equity ETF DXIV | 0.00% | 2.1K | 0.53% |
| 9 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 148.5K | 0.22% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 95.6K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andrea Di Santo | Chief Executive Officer & Director | 424.5K | male |
| Fausto Manzana | Executive Chairman | 424.5K | male |
| Dario Manzana | Executive Director | 49.4K | male |
| Matteo Santoro | General Manager | 43.8K | — |
| Federica Fiamingo | Manager & In-Charge of Financial Reporting & Vice Chairman | — | — |
| Laria Manzana | Company Secretary | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GPI.MI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
